TD Cowen Keeps Their Buy Rating on Jasper Therapeutics (JSPR)
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Werber covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals, Argenx Se, and Amgen. According to TipRanks, Werber has an average return of 5.2% and a 46.89% success rate on recommended stocks.
Jasper Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $60.38.
Based on Jasper Therapeutics' latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.17 million and a net profit of $46.95 million. In comparison, last year the company earned a revenue of $2.05 million and had a GAAP net loss of $16.58 million
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)
Barclays analyst Yihan Li maintained a Buy rating on Galderma Group AG on July 25 and set a price target of CHF140.00. The company's shares closed last Friday at CHF134.50. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Li is ranked #6568 out of 9862 analysts. Galderma Group AG has an analyst consensus of Strong Buy, with a price target consensus of CHF130.52, which is a -2.96% downside from current levels. In a report released on July 25, Citi also maintained a Buy rating on the stock with a CHF140.00 price target. Based on Galderma Group AG's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of CHF1.93 billion and a net profit of CHF160.43 million. In comparison, last year the company earned a revenue of CHF1.84 billion and had a GAAP net loss of CHF54.18 million
Business Insider
an hour ago
- Business Insider
Barclays Remains a Buy on Cadence Bank (CADE)
In a report released on July 25, Jared Shaw from Barclays maintained a Buy rating on Cadence Bank, with a price target of $43.00. The company's shares closed last Friday at $36.42. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Shaw is a 3-star analyst with an average return of 1.1% and a 53.28% success rate. Shaw covers the Financial sector, focusing on stocks such as UMB Financial, Cadence Bank, and BankUnited. In addition to Barclays, Cadence Bank also received a Buy from Morgan Stanley's Manan Gosalia in a report issued on July 25. However, on July 24, RBC Capital maintained a Hold rating on Cadence Bank (NYSE: CADE). Based on Cadence Bank's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $683.78 million and a net profit of $133.22 million. In comparison, last year the company earned a revenue of $720.9 million and had a net profit of $116.98 million
Business Insider
an hour ago
- Business Insider
Barclays Keeps Their Hold Rating on Treatt plc (TET)
In a report released on July 25, Setu Sharda from Barclays maintained a Hold rating on Treatt plc, with a price target of £2.20. The company's shares closed last Friday at p206.00. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Sharda is an analyst with an average return of -13.3% and a 26.67% success rate. Sharda covers the Basic Materials sector, focusing on stocks such as AAK AB, Treatt plc, and Corbion NV. In addition to Barclays, Treatt plc also received a Hold from TR | OpenAI – 4o's Dorian Reaxon in a report issued on July 26. However, on July 25, Berenberg Bank maintained a Buy rating on Treatt plc (LSE: TET). TET market cap is currently £121.4M and has a P/E ratio of 11.17.
